Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC
Titel:
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC
Auteur:
Saw, Stephanie P.L. Low, Yi Fen Lai, Gillianne G.Y. Chan, Landon L. Wong, Wesley K.Y. Tsui, Giselle Chen, Olivia H. Seet, Amanda O.L. Tan, Wei Chong Tan, Aaron C. Chan, Johan W.K. Teh, Yi Lin Tan, Wan-Ling Ng, Quan Sing Ang, Mei-Kim Kanesvaran, Ravindran Lim, Darren W.T. Tan, Daniel S.W. Mok, Tony S.K. Li, Molly S.C.